Search

  1. ProQR to Present at the Chardan Genetic Medicines Conference

    Press release

    … ProQR to Present at the Chardan Genetic Medicines Conference … LEIDEN, the Netherlands, Oct. 02, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … Presenter : Gerard Platenburg, chief innovation officer of ProQR Presentation : Tuesday, October 9, 2018 at 8:00 am ET …

  4. ProQR Prices $90.6 Million Underwritten Public Offering of Ordinary Shares

    Press release

    … ProQR Prices $90.6 Million Underwritten Public Offering of … and CAMBRIDGE, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a biopharmaceutical … share.  All of the shares are being offered by ProQR.  The offering is expected to close on September 11, …

  5. ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences

    Press release

    LEIDEN, Netherlands & CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced that it will p

  8. ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares

    Press release

    … ProQR Prices $50 Million Underwritten Public Offering of … and CAMBRIDGE, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a biopharmaceutical … of $5.50 per share. All of the shares are being offered by ProQR. In addition, ProQR has granted the underwriters a …

  9. ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer

    Press release

    … ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific … medicine platform from David Rodman, MD, who is departing ProQR. Dr. Shams brings to ProQR deep ophthalmology, … provide strategic direction, oversight, and execution for ProQR’s research and early development efforts. This entails …

    Naveed Shams